title: Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-Line Long-Term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial.
authors.forename: Samir S
authors.initials: SS
authors.lastname: Taneja
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D004164:Diphosphonates; D018572:Disease-Free Survival; D000077143:Docetaxel; D006801:Humans; D007093:Imidazoles; D008297:Male; D011471:Prostatic Neoplasms; D043823:Taxoids; D000077211:Zoledronic Acid
chemical_list: D004164:Diphosphonates; D007093:Imidazoles; D043823:Taxoids; D000077143:Docetaxel; D000077211:Zoledronic Acid